E
Titan Pharmaceuticals, Inc. TTNP
$4.99 $0.091.84% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- 0.00 4.00K
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- 0.00 4.00K
Cost of Revenue -- -- -- 487.00K 911.00K
Gross Profit -- -- -- -487.00K -907.00K
SG&A Expenses 2.61M 4.03M 4.56M 5.34M 6.22M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 2.61M 4.03M 4.56M 5.82M 7.13M
Operating Income -2.61M -4.03M -4.56M -5.82M -7.13M
Income Before Tax -2.81M -4.21M -4.71M -5.89M -5.46M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -2.81 -4.21 -4.71 -5.89 -5.46
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -2.81M -4.21M -4.71M -5.89M -5.46M
EBIT -2.61M -4.03M -4.56M -5.82M -7.13M
EBITDA -2.61M -4.02M -4.55M -5.81M -7.09M
EPS Basic -2.96 -4.61 -5.23 -6.98 -6.59
Normalized Basic EPS -1.85 -2.88 -3.27 -4.38 -5.58
EPS Diluted -2.96 -4.61 -5.23 -6.98 -6.59
Normalized Diluted EPS -1.85 -2.88 -3.27 -4.38 -5.58
Average Basic Shares Outstanding 3.81M 3.66M 3.60M 3.44M 3.27M
Average Diluted Shares Outstanding 3.81M 3.66M 3.60M 3.44M 3.27M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --